Does rosuvastatin delay progression of atherosclerosis in people with HIV infection at moderate cardiovascular risk? A randomized, placebo-controlled trial
Phase of Trial: Phase IV
Latest Information Update: 27 Feb 2017
At a glance
- Drugs Rosuvastatin (Primary)
- Indications Atherosclerosis
- Focus Therapeutic Use
- 07 Jun 2017 Biomarkers information updated
- 01 Jul 2013 Status changed from active, no longer recruiting to recruiting as reported by ClinicalTrials.gov.
- 18 Mar 2013 Additional lead trial centre identified as reported by ClinicalTrials.gov.